Jean-Pierre Raufman, who made frequent trips from Brooklyn to the Bronx VA lab carrying test tubes in his Toyota Camry, the team isolated a peptide molecule they named exendin-4
Depending on the severity and nature of symptoms, your provider may recommend adjusting the dose, temporarily discontinuing treatment, or switching to an alternative approach
Physiology of the incretin hormones, GIP and GLP-1-regulation of release and posttranslational modifications
Planning your exit strategy Tirzepatide treatment is not meant to continue indefinitely at the same dose
Healthcare providers should monitor blood glucose closely and adjust medications appropriately
GLP-1 patches are an emerging technology being studied as an alternative to injectable GLP-1 receptor agonists, which are medications commonly prescribed for type 2 diabetes and weight management